Key facts
- This page summarizes Michael Forer's Form 3 filing for GH Research PLC (GHRS).
- 0 reported transactions and 5 derivative rows are listed below.
- Accepted by SEC: 02 Apr 2026, 17:35.
Michael Forer - 18 Mar 2026 Form 3 Insider Report for GH Research PLC (GHRS)
- Reporting relationship
- Director
- Issuer ticker
- GHRS
- Reported as of
- 18 Mar 2026
- Net transaction value
- $0
- Reporting owner signature
- /s/ Michael Forer
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Michael Forer filed Form 3 for GH Research PLC (GHRS) on 02 Apr 2026.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
CIK 0002126827
Primary reporting owner
Forer Michael
- Relationship
- Director
- Address
- C/O GH RESEARCH PLC, JOSHUA DAWSON HOUSE, DAWSON STREET, DUBLIN, IRELAND
- Signature
- /s/ Michael Forer
- Signature date
- 01 Apr 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
GHRS
holding
Ordinary Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 45,509
- Date
- 18 Mar 2026
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
GHRS
holding
Derivative
Share Options (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 Mar 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 6,633
- Exercise price
- $0.0250
- Footnotes
- F1
GHRS
holding
Derivative
Share Options (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 Mar 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 5,508
- Exercise price
- $0.0250
- Footnotes
- F2
GHRS
holding
Derivative
Share Options (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 Mar 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 5,532
- Exercise price
- $0.0250
- Footnotes
- F3
GHRS
holding
Derivative
Share Options (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 Mar 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 50,000
- Exercise price
- $0.0250
- Footnotes
- F4
GHRS
holding
Derivative
Share Options (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 Mar 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 4,667
- Exercise price
- $0.0250
- Footnotes
- F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 5 footnotes
Footnote F1
The share options are fully vested and exercisable.
Footnote F2
The share options are fully vested and, subject to the rules of the GH Research PLC Share Option Plan, may be exercised between the second and seventh anniversary of June 22, 2024.
Footnote F3
The share options are fully vested and, subject to the rules of the GH Research PLC Share Option Plan, may be exercised between the second and seventh anniversary of July 6, 2024.
Footnote F4
The share options vested as to 25% on December 9, 2025, and the remaining share options vest in equal monthly installments for three years thereafter.
Footnote F5
The share options are fully vested and, subject to the rules of the GH Research PLC Share Option Plan, may be exercised between the second and seventh anniversary of September 3, 2025.